The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells

Biochemical Pharmacology

Volumn 68, Issue 4, 2004, Pages 621-629

  Verbeek, Richard ^a   Plomp, Arianne C ^a   Van Tol, Eric A F ^b   Van Noort, Johannes M ^a  

^a TNO   (Netherlands)

^b NUMICO RESEARCH   (Netherlands)

Author keywords

Apigenin; Autoimmune; EAE; experimental autoimmune encephalomyelitis; Flavonoids; IFN; IL; interferon; interleukin; Luteolin; MS; multiple sclerosis; Multiple sclerosis; PLP; proteolipid protein; T cells

Indexed keywords

APIGENIN; CRYSTALLIN; GAMMA INTERFERON; HESPERETIN; LUTEOLIN; MORIN; PROTEOLIPID PROTEIN; QUERCETIN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG INHIBITION; EVALUATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; APIGENIN; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; INTERFERON TYPE II; LUTEOLIN; LYMPHOKINES; MICE; T-LYMPHOCYTES;

EID: 3242720446     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.05.012     Document Type: Article

References (53)

1. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer. 20:1993;21-29
2. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56:1998;317-333
3. Hollman P.C., Katan M.B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37:1999;937-942
4. Hollman P.C., Katan M.B. Health effects and bioavailability of dietary flavonols. Free Radic. Res. 31(Suppl.):1999;S75-S80
5. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33:1995;1061-1080
6. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342:1993;1007-1011
7. Knekt P., Jarvinen R., Reunanen A., Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312:1996;478-481
8. Wenzel U., Kuntz S., Brendel M.D., Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 60:2000;3823-3831
9. Knekt P., Jarvinen R., Seppanen R., Hellovaara M., Teppo L., Pukkala E., et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 146:1997;223-230
10. Wang H.K. The therapeutic potential of flavonoids. Exp. Opin. Invest. Drugs. 9:2000;2103-2119
11. Huk I., Brovkovych V., Nanobash V.J., Weigel G., Neumayer C., Partyka L., et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br. J. Surg. 85:1998;1080-1085
12. Middleton E.J., Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 43:1992;1167-1179
13. Farber D.L. T cell memory: heterogeneity and mechanisms. Clin. Immunol. 95:2000;173-181
14. Robak J., Gryglewski R.J. Bioactivity of flavonoids. Pol. J. Pharmacol. 48:1996;555-564
15. Nijveldt R.J., van Nood E., van Hoorn D.E., Boelens P.G., van Norren K., van Leeuwen P.A. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74:2001;418-425
16. Yoshida M., Yamamoto M., Nikaido T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 52:1992;6676-6681
17. Schwartz A., Sutton S.L., Middleton E.J. Quercetin inhibition of the induction and function of cytotoxic T lymphocytes. Immunopharmacology. 4:1982;125-138
18. Lee S.J., Choi J.H., Son K.H., Chang H.W., Kang S.S., Kim H.P. Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci. 57:1995;551-558
19. Namgoong S.Y., Son K.H., Chang H.W., Kang S.S., Kim H.P. Effects of naturally occurring flavonoids on mitogen-induced lymphocyte proliferation and mixed lymphocyte culture. Life Sci. 54:1994;313-320
20. Atluru S., Atluru D. Evidence that genistein, a protein-tyrosine kinase inhibitor, inhibits CD28 monoclonal-antibody-stimulated human T cell proliferation. Transplantation. 51:1991;448-450
21. Jenkins M.K., Khoruts A., Ingulli E., Mueller D.L., McSorley S.J., Reinhardt R.L., et al. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:2001;23-45
22. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science. 290:2000;92-97
23. Hussain S.F., Anderson C.F., Farber D.L. Differential SLP-76 expression and TCR-mediated signaling in effector and memory CD4 T cells. J. Immunol. 168:2002;1557-1565
24. Noseworthy J.H. Progress in determining the causes and treatment of multiple sclerosis. Nature. 399(6738 Suppl.):1999;A40-A47
25. Wingerchuk D.M., Lucchinetti C.F., Noseworthy J.H. Multiple sclerosis: current pathophysiological concepts. Lab. Invest. 81:2001;263-281
26. Wekerle H. Immune pathogenesis of multiple sclerosis. Brain autoimmune reactivity and its control by neuronal function. Mult. Scler. 4:1998;136-137
27. van Noort J.M., van Sechel A.C., Bajramovic J.J., el Ouagmiri M., Polman C.H., Lassmann H., et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature. 375:1995;798-801
28. van Noort J.M., Bajramovic J.J., Plomp A.C., van Stipdonk M.J. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis. J. Neuroimmunol. 105:2000;46-57
29. Panitch H.S., Bever C.T.J. Clinical trials of interferons in multiple sclerosis. What have we learned? J. Neuroimmunol. 46:1993;155-164
30. van Stipdonk M.J., Willems A.A., Plomp A.C., van Noort J.M., Boog C.J. Tolerance controls encephalitogenicity of alpha B-crystallin in the Lewis rat. J. Neuroimmunol. 103:2000;103-111
31. van Stipdonk M.J., Willems A.A., Verbeek R., Boog C.J., van Noort J.M. T- and B-cell nonresponsiveness to self-alpha B-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. Cell. Immunol. 204:2000;128-134
32. Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol. Rev. 184:2001;129-135
33. Renno T., Lin J.Y., Piccirillo C., Antel J., Owens T. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49:1994;1-7
34. Lee W.R., Shen S.C., Lin H.Y., Hou W.C., Yang L.L., Chen Y.C. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem. Pharmacol. 63:2002;225-236
35. Schwartz A., Middleton E.J. Comparison of the effects of quercetin with those of other flavonoids on the generation and effector function of cytotoxic T lymphocytes. Immunopharmacology. 7:1984;115-126
36. Polak T., Schlaf G., Scholl U., Krome-Cesar C., Mader M., Felgenhauer K., et al. Characterization of the human T cell response against the neuronal protein synapsin in patients with multiple sclerosis. J. Neuroimmunol. 115:2001;176-181
37. Rohowsky-Kochan C., Molinaro D., Cook S.D. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis. Mult. Scler. 6:2000;69-77
38. Di Rosa F., Francesconi A., Di Virgilio A., Finocchi L., Santilio I., Barnaba V. Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis. Eur. J. Immunol. 28:1998;3893-3903
39. Hall S.R., Heffernan B.M., Thompson N.T., Rowan W.C. CD4+ CD45RA+ and CD4+ CD45RO+ T cells differ in their TCR-associated signaling responses. Eur. J. Immunol. 29:1999;2098-2106
40. Dubey C., Croft M., Swain S.L. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157:1996;3280-3289
41. Erlund I., Kosonen T., Alfthan G., Maenpaa J., Perttunen K., Kenraali J., et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 56:2000;545-553
42. Nielsen S.E., Young J.F., Daneshvar B., Lauridsen S.T., Knuthsen P., Sandstrom B., et al. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion. Br. J. Nutr. 81:1999;447-455
43. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 130:2000;2073S-2085S
44. Ameer B., Weintraub R.A., Johnson J.V., Yost R.A., Rouseff R.L. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 60:1996;34-40
45. Hollman P.C., Bijsman M.N., van Gameren Y., Cnossen E.P., de Vries J.H., Katan M.B. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free. Radic. Res. 31(6):1999;569-573
46. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41:2001;492-499
47. Manach C., Morand C., Texier O., Favier M.L., Agullo G., Demigne C., et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 125:1995;1911-1922
48. Rice-Evans C. Flavonoid antioxidants. Curr. Med. Chem. 8:2001;797-807
49. Cos P., Ying L., Calomme M., Hu J.P., Cimanga K., Van Poel B., et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod. 61:1998;71-76
50. van Hoorn D.E., Nijveldt R.J., van Leeuwen P.A., Hofman Z., M'Rabet L., De Bont D.B., et al. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur. J. Pharmacol. 451:2002;111-118
51. Di Pietro A., Conseil G.J.M., Dayan G., Baubichon-Cortay H., Trompier D., Steinfels E., et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol. Life Sci. 59:2002;307-322
52. Williamson G., Faulkner K., Plumb G.W. Glucosinolates and phenolics as antioxidants from plant foods. Eur. J. Cancer Prev. 7:1998;17-21
53. Fesen M.R., Pommier Y., Leteurtre F., Hiroguchi S., Yung J., Kohn K.W. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48(3):1994;595-608